Controlled substance. Prescription required from a registered healthcare provider under the Narcotic Drugs and Psychotropic Substances Act.
What it treats
Which conditions is Nitrazepam used for?
Overview
What is Nitrazepam?
Nitrazepam is a long-acting benzodiazepine used in two specific contexts: for severe short-term insomnia in adults when other approaches have not worked, and for certain childhood epilepsy syndromes, particularly infantile spasms and Lennox-Gastaut syndrome.
It is listed in Kenya's Essential Medicines List 2023 at Level 4-6. Because it remains in the body for a long time, it can cause significant next-day drowsiness and cognitive impairment.
For sleep difficulties, non-medicine approaches should always be tried before medicines. When a medicine is needed, nitrazepam should be used at the lowest effective dose for the shortest possible time.
How it works
What does it do in the brain?
Formulations in Kenya
How is it available?
Availability across Africa
Where is it available in Africa and what is it called?
| Country | Common Brand Name(s) | Notes |
|---|---|---|
| South Africa | Mogadon, Nitrazepam (generic) | Available on prescription in both sectors; mainly used for childhood epilepsy syndromes. |
| Nigeria | Mogadon | Available at select teaching hospitals for childhood epilepsy; controlled substance. |
| Ghana | Nitrazepam (generic) | Available at Korle-Bu and select specialist pharmacies. |
| Uganda | Nitrazepam (generic) | Available at Butabika Hospital pharmacy and select private pharmacies in Kampala. |
Side effects
What might you feel while taking it?
These are the most commonly reported effects. Not everyone experiences them, and many settle within the first few weeks.
- Next-day drowsiness and impaired alertness
- Memory impairment
- Dizziness and poor coordination, increases fall risk
- Muscle weakness
- Tolerance, effectiveness reduces with regular use
- Rebound insomnia when the medicine is stopped
- Dependence develops relatively quickly with regular use
- In elderly patients, the prolonged sedation significantly raises the risk of falls and fractures
- Breathing difficulty when combined with alcohol or other sedating substances
Who should not take it
Important warnings before starting
- Sleep apnoea
- Severe respiratory insufficiency
- Myasthenia gravis
- Severe liver disease
Special care needed
Situations that need extra attention
- Do not drive or operate machinery the day after taking nitrazepam
- Do not take with alcohol
- Elderly patients are particularly vulnerable to falls and cognitive effects
- Use for the shortest possible time, typically no more than two to four weeks for insomnia
- Discuss a stopping plan with your doctor from the start of treatment
Not recommended during pregnancy. Speak to your doctor if you become pregnant while taking this medicine.
Passes into breast milk. Not recommended during breastfeeding.
Other medicines
Medicines and substances that can interact with it
- Alcohol: Significantly amplifies sedation and respiratory depression. Avoid entirely.
- Opioid pain medicines and other sedating drugs: Combined sedation can become dangerous.
Tests and follow-up
What your doctor will monitor
- Duration of use reviewed at every appointment
- Daytime functioning and alertness, particularly in elderly patients
- Signs of dependence or difficulty reducing the medicine
Stopping this medicine
What happens if you stop taking it?
In Kenya
What you should know about this medicine in Kenya
Nitrazepam is available in Kenya at Level 4 and above. Given its prolonged action and next-day sedation, it is generally not the first choice for insomnia management.
Sleep problems in Kenya are frequently secondary to anxiety, depression, or difficult life circumstances. Addressing the underlying cause is more effective than long-term use of any hypnotic medicine.
Awareness of its controlled status and dependence potential is important for both prescribers and patients.
Sources
References
- Ministry of Health, Kenya. (2023). Kenya Essential Medicines List 2023. Nairobi: Ministry of Health.
- Ministry of Health, Kenya. (2023). Kenya National Medicines Formulary, 1st Edition. Nairobi: Ministry of Health.
- World Health Organization. (2023). Model List of Essential Medicines, 23rd Edition. Geneva: WHO.